Endoplasmic reticulum-resident selenoproteins as regulators of calcium signaling and homeostasis

Cell Calcium

Volumn 70, Issue , 2018, Pages 76-86

  Pitts, Matthew W ^a   Hoffmann, Peter R ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Chaperone; ER stress; Inositol 1,4,5 triphosphate receptor; Protein folding; Selenium; SERCA pump

Indexed keywords

IODIDE PEROXIDASE; IODOTHYRONINE DEIODINASE 2; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SELENOPROTEIN; SELENOPROTEIN F; SELENOPROTEIN K; SELENOPROTEIN M; SELENOPROTEIN N; SELENOPROTEIN S; SELENOPROTEIN T; THYROID HORMONE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; HUMAN; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; ANIMAL; BIOLOGICAL MODEL; HOMEOSTASIS; METABOLISM;

ANIMALS; CALCIUM SIGNALING; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; HOMEOSTASIS; HUMANS; MODELS, BIOLOGICAL; SELENOPROTEINS;

EID: 85019121274     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2017.05.001     Document Type: Review

References (121)

1. Rayman, M.P., Selenium and human health. Lancet 379 (2012), 1256–1268.
2. Bulteau, A.L., Chavatte, L., Update on selenoprotein biosynthesis. Antioxid. Redox Signal. 23 (2015), 775–794.
3. Kryukov, G.V., Castellano, S., Novoselov, S.V., Lobanov, A.V., Zehtab, O., Guigo, R., Gladyshev, V.N., Characterization of mammalian selenoproteomes. Science 300 (2003), 1439–1443.
4. Bosl, M.R., Takaku, K., Oshima, M., Nishimura, S., Taketo, M.M., Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp). Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 5531–5534.
5. Schweizer, U., Fradejas-Villar, N., Why 21? The significance of selenoproteins for human health revealed by inborn errors of metabolism. FASEB J. 30 (2016), 3669–3681.
6. Dumitrescu, A.M., Di Cosmo, C., Liao, X.H., Weiss, R.E., Refetoff, S., The syndrome of inherited partial SBP2 deficiency in humans. Antioxid. Redox Signal. 12 (2010), 905–920.
7. Hondal, R.J., Marino, S.M., Gladyshev, V.N., Selenocysteine in thiol/disulfide-like exchange reactions. Antioxid. Redox Signal. 18 (2013), 1675–1689.
8. Dardashti, R.N., Dery, L., Mousa, R., Dery, S., Reddy, P.S., Metanis, N., The chemistry of selenocysteine in proteins. Hatfield, D.L., Gladyshev, V.N., (eds.) Selenium: Its Molecular Biology and Role in Human Health, 2016, Springer, New York, 73–83.
9. Gladyshev, V.N., Arner, E.S., Berry, M.J., Brigelius-Flohe, R., Bruford, E.A., Burk, R.F., Carlson, B.A., Castellano, S., Chavatte, L., Conrad, M., Copeland, P.R., Diamond, A.M., Driscoll, D.M., Ferreiro, A., Flohe, L., Green, F.R., Guigo, R., Handy, D.E., Hatfield, D.L., Hesketh, J., Hoffmann, P.R., Holmgren, A., Hondal, R.J., Howard, M.T., Huang, K., Kim, H.Y., Kim, I.Y., Kohrle, J., Krol, A., Kryukov, G.V., Lee, B.J., Lee, B.C., Lei, X.G., Liu, Q., Lescure, A., Lobanov, A.V., Loscalzo, J., Maiorino, M., Mariotti, M., Sandeep Prabhu, K., Rayman, M.P., Rozovsky, S., Salinas, G., Schmidt, E.E., Schomburg, L., Schweizer, U., Simonovic, M., Sunde, R.A., Tsuji, P.A., Tweedie, S., Ursini, F., Whanger, P.D., Zhang, Y., Selenoprotein gene nomenclature. J. Biol. Chem. 291 (2016), 24036–24040.
10. Jousset, H., Frieden, M., Demaurex, N., STIM1 knockdown reveals that store-operated Ca2+ channels located close to sarco/endoplasmic Ca2+ ATPases (SERCA) pumps silently refill the endoplasmic reticulum. J. Biol. Chem. 282 (2007), 11456–11464.
11. Shchedrina, V.A., Zhang, Y., Labunskyy, V.M., Hatfield, D.L., Gladyshev, V.N., Structure-function relations, physiological roles, and evolution of mammalian ER-resident selenoproteins. Antioxid. Redox Signal. 12 (2010), 839–849.
12. Ambudkar, I.S., de Souza, L.B., Ong, H.L., TRPC1, Orai1, and STIM1 in SOCE: Friends in tight spaces. Cell Calcium, 2016, 10.1016/j.ceca.2016.12.009 Dec 30. pii: S0143-4160(16)30218-4. [Epub ahead of print] Review. PMID:28089266.
13. Villalobos, C., Sobradillo, D., Hernandez-Morales, M., Nunez, L., Remodeling of calcium entry pathways in cancer. Adv. Exp. Med. Biol. 898 (2016), 449–466.
14. Villalobos, C., Sobradillo, D., Hernández-Morales, M., Núñez, L., Calcium remodeling in colorectal cancer. Biochim. Biophys. Acta, 2017, 10.1016/j.bbamcr.2017.01.005 Jan 10. pii: S0167-4889(17)30007-1. [Epub ahead of print] Review. PMID:28087343.
15. Walter, P., Ron, D., The unfolded protein response: from stress pathway to homeostatic regulation. Science 334 (2011), 1081–1086.
16. Pedruzzi, E., Guichard, C., Ollivier, V., Driss, F., Fay, M., Prunet, C., Marie, J.C., Pouzet, C., Samadi, M., Elbim, C., O'Dowd, Y., Bens, M., Vandewalle, A., Gougerot-Pocidalo, M.A., Lizard, G., Ogier-Denis, E., NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol. Cell. Biol. 24 (2004), 10703–10717.
17. Hourihan, J.M., Moronetti Mazzeo, L.E., Fernandez-Cardenas, L.P., Blackwell, T.K., Cysteine sulfenylation directs IRE-1 to activate the SKN-1/Nrf2 antioxidant response. Mol. Cell 63 (2016), 553–566.
18. Li, M., Baumeister, P., Roy, B., Phan, T., Foti, D., Luo, S., Lee, A.S., ATF6 as a transcription activator of the endoplasmic reticulum stress element: thapsigargin stress-induced changes and synergistic interactions with NF-Y and YY1. Mol. Cell. Biol. 20 (2000), 5096–5106.
19. Selvaraj, S., Sun, Y., Watt, J.A., Wang, S., Lei, S., Birnbaumer, L., Singh, B.B., Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signaling. J. Clin. Invest. 122 (2012), 1354–1367.
20. Gardner, B.M., Pincus, D., Gotthardt, K., Gallagher, C.M., Walter, P., Endoplasmic reticulum stress sensing in the unfolded protein response. Cold Spring Harb Perspect Biol, 5, 2013, a013169.
21. Tabas, I., Ron, D., Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell Biol. 13 (2011), 184–190.
22. Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J., Greenberg, M.E., Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (1995), 1326–1331.
23. Ventura, J.J., Hubner, A., Zhang, C., Flavell, R.A., Shokat, K.M., Davis, R.J., Chemical genetic analysis of the time course of signal transduction by JNK. Mol. Cell 21 (2006), 701–710.
24. Li, G., Scull, C., Ozcan, L., Tabas, I., NADPH oxidase links endoplasmic reticulum stress, oxidative stress, and PKR activation to induce apoptosis. J. Cell Biol. 191 (2010), 1113–1125.
25. Deniaud, A., Sharaf el dein, O., Maillier, E., Poncet, D., Kroemer, G., Lemaire, C., Brenner, C., Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis. Oncogene 27 (2008), 285–299.
26. Ozcan, U., Cao, Q., Yilmaz, E., Lee, A.H., Iwakoshi, N.N., Ozdelen, E., Tuncman, G., Gorgun, C., Glimcher, L.H., Hotamisligil, G.S., Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306 (2004), 457–461.
27. Ozcan, L., Tabas, I., Role of endoplasmic reticulum stress in metabolic disease and other disorders. Annu. Rev. Med. 63 (2012), 317–328.
28. Myoishi, M., Hao, H., Minamino, T., Watanabe, K., Nishihira, K., Hatakeyama, K., Asada, Y., Okada, K., Ishibashi-Ueda, H., Gabbiani, G., Bochaton-Piallat, M.L., Mochizuki, N., Kitakaze, M., Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome. Circulation 116 (2007), 1226–1233.
29. Mattson, M.P., LaFerla, F.M., Chan, S.L., Leissring, M.A., Shepel, P.N., Geiger, J.D., Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 23 (2000), 222–229.
30. Schauble, N., Lang, S., Jung, M., Cappel, S., Schorr, S., Ulucan, O., Linxweiler, J., Dudek, J., Blum, R., Helms, V., Paton, A.W., Paton, J.C., Cavalie, A., Zimmermann, R., BiP-mediated closing of the Sec61 channel limits Ca2+ leakage from the ER. EMBO J. 31 (2012), 3282–3296.
31. Hammadi, M., Oulidi, A., Gackiere, F., Katsogiannou, M., Slomianny, C., Roudbaraki, M., Dewailly, E., Delcourt, P., Lepage, G., Lotteau, S., Ducreux, S., Prevarskaya, N., Van Coppenolle, F., Modulation of ER stress and apoptosis by endoplasmic reticulum calcium leak via translocon during unfolded protein response: involvement of GRP78. FASEB J. 27 (2013), 1600–1609.
32. Terentyev, D., Gyorke, I., Belevych, A.E., Terentyeva, R., Sridhar, A., Nishijima, Y., de Blanco, E.C., Khanna, S., Sen, C.K., Cardounel, A.J., Carnes, C.A., Gyorke, S., Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+ leak in chronic heart failure. Circ. Res. 103 (2008), 1466–1472.
33. Andersson, D.C., Betzenhauser, M.J., Reiken, S., Meli, A.C., Umanskaya, A., Xie, W., Shiomi, T., Zalk, R., Lacampagne, A., Marks, A.R., Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. Cell Metab. 14 (2011), 196–207.
34. Khan, S.A., Rossi, A.M., Riley, A.M., Potter, B.V., Taylor, C.W., Subtype-selective regulation of IP(3) receptors by thimerosal via cysteine residues within the IP(3)-binding core and suppressor domain. Biochem. J. 451 (2013), 177–184.
35. Bansaghi, S., Golenar, T., Madesh, M., Csordas, G., RamachandraRao, S., Sharma, K., Yule, D.I., Joseph, S.K., Hajnoczky, G., Isoform- and species-specific control of inositol 1,4,5-trisphosphate (IP3) receptors by reactive oxygen species. J. Biol. Chem. 289 (2014), 8170–8181.
36. Zheng, Y., Zhong, L., Shen, X., Effect of selenium-supplement on the calcium signaling in human endothelial cells. J. Cell. Physiol. 205 (2005), 97–106.
37. Hwang, C., Sinskey, A.J., Lodish, H.F., Oxidized redox state of glutathione in the endoplasmic reticulum. Science 257 (1992), 1496–1502.
38. Birk, J., Meyer, M., Aller, I., Hansen, H.G., Odermatt, A., Dick, T.P., Meyer, A.J., Appenzeller-Herzog, C., Endoplasmic reticulum: reduced and oxidized glutathione revisited. J. Cell Sci. 126 (2013), 1604–1617.
39. Enyedi, B., Varnai, P., Geiszt, M., Redox state of the endoplasmic reticulum is controlled by Ero1L-alpha and intraluminal calcium. Antioxid. Redox Signal. 13 (2010), 721–729.
40. Li, Y., Camacho, P., Ca2+-dependent redox modulation of SERCA 2b by ERp57. J. Cell Biol. 164 (2004), 35–46.
41. Gladyshev, V.N., Jeang, K.T., Wootton, J.C., Hatfield, D.L., A new human selenium-containing protein. Purification, characterization, and cDNA sequence. J. Biol. Chem. 273 (1998), 8910–8915.
42. Korotkov, K.V., Kumaraswamy, E., Zhou, Y., Hatfield, D.L., Gladyshev, V.N., Association between the 15-kDa selenoprotein and UDP-glucose:glycoprotein glucosyltransferase in the endoplasmic reticulum of mammalian cells. J. Biol. Chem. 276 (2001), 15330–15336.
43. Labunskyy, V.M., Ferguson, A.D., Fomenko, D.E., Chelliah, Y., Hatfield, D.L., Gladyshev, V.N., A novel cysteine-rich domain of Sep15 mediates the interaction with UDP-glucose:glycoprotein glucosyltransferase. J. Biol. Chem. 280 (2005), 37839–37845.
44. Ferguson, A.D., Labunskyy, V.M., Fomenko, D.E., Arac, D., Chelliah, Y., Amezcua, C.A., Rizo, J., Gladyshev, V.N., Deisenhofer, J., NMR structures of the selenoproteins Sep15 and SelM reveal redox activity of a new thioredoxin-like family. J. Biol. Chem. 281 (2006), 3536–3543.
45. Lynes, E.M., Raturi, A., Shenkman, M., Ortiz Sandoval, C., Yap, M.C., Wu, J., Janowicz, A., Myhill, N., Benson, M.D., Campbell, R.E., Berthiaume, L.G., Lederkremer, G.Z., Simmen, T., Palmitoylation is the switch that assigns calnexin to quality control or ER Ca2+ signaling. J. Cell Sci. 126 (2013), 3893–3903.
46. Labunskyy, V.M., Yoo, M.H., Hatfield, D.L., Gladyshev, V.N., Sep15 a thioredoxin-like selenoprotein, is involved in the unfolded protein response and differentially regulated by adaptive and acute ER stresses. Biochemistry 48 (2009), 8458–8465.
47. Kumaraswamy, E., Malykh, A., Korotkov, K.V., Kozyavkin, S., Hu, Y., Kwon, S.Y., Moustafa, M.E., Carlson, B.A., Berry, M.J., Lee, B.J., Hatfield, D.L., Diamond, A.M., Gladyshev, V.N., Structure-expression relationships of the 15-kDa selenoprotein gene. Possible role of the protein in cancer etiology. J. Biol. Chem. 275 (2000), 35540–35547.
48. Guariniello, S., Di Bernardo, G., Colonna, G., Cammarota, M., Castello, G., Costantini, S., Evaluation of the selenotranscriptome expression in two hepatocellular carcinoma cell lines. Anal. Cell. Pathol. (Amst.), 2015, 2015, 419561.
49. Tsuji, P.A., Carlson, B.A., Yoo, M.H., Naranjo-Suarez, S., Xu, X.M., He, Y., Asaki, E., Seifried, H.E., Reinhold, W.C., Davis, C.D., Gladyshev, V.N., Hatfield, D.L., The 15 kDa selenoprotein and thioredoxin reductase 1 promote colon cancer by different pathways. PLoS One, 10, 2015, e0124487.
50. Tsuji, P.A., Naranjo-Suarez, S., Carlson, B.A., Tobe, R., Yoo, M.H., Davis, C.D., Deficiency in the 15 kDa selenoprotein inhibits human colon cancer cell growth. Nutrients 3 (2011), 805–817.
51. Tsuji, P.A., Carlson, B.A., Naranjo-Suarez, S., Yoo, M.H., Xu, X.M., Fomenko, D.E., Gladyshev, V.N., Hatfield, D.L., Davis, C.D., Knockout of the 15 kDa selenoprotein protects against chemically-induced aberrant crypt formation in mice. PLoS One, 7, 2012, e50574.
52. Kasaikina, M.V., Fomenko, D.E., Labunskyy, V.M., Lachke, S.A., Qiu, W., Moncaster, J.A., Zhang, J., Wojnarowicz, M.W. Jr., Natarajan, S.K., Malinouski, M., Schweizer, U., Tsuji, P.A., Carlson, B.A., Maas, R.L., Lou, M.F., Goldstein, L.E., Hatfield, D.L., Gladyshev, V.N., Roles of the 15-kDa selenoprotein (Sep15) in redox homeostasis and cataract development revealed by the analysis of Sep 15 knockout mice. J. Biol. Chem. 286 (2011), 33203–33212.
53. Verma, S., Hoffmann, F.W., Kumar, M., Huang, Z., Roe, K., Nguyen-Wu, E., Hashimoto, A.S., Hoffmann, P.R., Selenoprotein K knockout mice exhibit deficient calcium flux in immune cells and impaired immune responses. J. Immunol. 186 (2011), 2127–2137.
54. Liu, J., Rozovsky, S., Membrane-bound selenoproteins. Antioxid. Redox Signal. 23 (2015), 795–813.
55. Polo, A., Colonna, G., Guariniello, S., Ciliberto, G., Costantini, S., Deducing the functional characteristics of the human selenoprotein SELK from the structural properties of its intrinsically disordered C-terminal domain. Mol. Biosyst. 12 (2016), 758–772.
56. Du, S., Zhou, J., Jia, Y., Huang, K., SelK is a novel ER stress-regulated protein and protects HepG2 cells from ER stress agent-induced apoptosis. Arch. Biochem. Biophys. 502 (2010), 137–143.
57. Shchedrina, V.A., Everley, R.A., Zhang, Y., Gygi, S.P., Hatfield, D.L., Gladyshev, V.N., Selenoprotein K binds multiprotein complexes and is involved in the regulation of endoplasmic reticulum homeostasis. J. Biol. Chem. 286 (2011), 42937–42948.
58. Lee, J.H., Park, K.J., Jang, J.K., Jeon, Y.H., Ko, K.Y., Kwon, J.H., Lee, S.R., Kim, I.Y., Selenoprotein S-dependent selenoprotein K binding to p97(VCP) protein is essential for endoplasmic reticulum-associated degradation. J. Biol. Chem. 290 (2015), 29941–29952.
59. Fredericks, G.J., Hoffmann, F.W., Rose, A.H., Osterheld, H.J., Hess, F.M., Mercier, F., Hoffmann, P.R., Stable expression and function of the inositol 1,4,5-triphosphate receptor requires palmitoylation by a DHHC6/selenoprotein K complex. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 16478–16483.
60. Reich, H.J., Hondal, R.J., Why nature chose selenium. ACS Chem. Biol. 11 (2016), 821–841.
61. Liu, J., Zhang, Z., Rozovsky, S., Selenoprotein K form an intermolecular diselenide bond with unusually high redox potential. FEBS Lett. 588 (2014), 3311–3321.
62. Wang, C., Li, R., Huang, Y., Wang, M., Yang, F., Huang, D., Wu, C., Li, Y., Tang, Y., Zhang, R., Cheng, J., Selenoprotein K modulate intracellular free Ca2+ by regulating expression of calcium homoeostasis endoplasmic reticulum protein. Biochem. Biophys. Res. Commun. 484 (2017), 734–739.
63. Korotkov, K.V., Novoselov, S.V., Hatfield, D.L., Gladyshev, V.N., Mammalian selenoprotein in which selenocysteine (Sec) incorporation is supported by a new form of Sec insertion sequence element. Mol. Cell. Biol. 22 (2002), 1402–1411.
64. Pitts, M.W., Reeves, M.A., Hashimoto, A.C., Ogawa, A., Kremer, P., Seale, L.A., Berry, M.J., Deletion of selenoprotein M leads to obesity without cognitive deficits. J. Biol. Chem. 288 (2013), 26121–26134.
65. Huang, J.Q., Ren, F.Z., Jiang, Y.Y., Lei, X., Characterization of selenoprotein M and its response to selenium deficiency in chicken brain. Biol. Trace Elem. Res. 170 (2016), 449–458.
66. Reeves, M.A., Bellinger, F.P., Berry, M.J., The neuroprotective functions of selenoprotein M and its role in cytosolic calcium regulation. Antioxid. Redox Signal. 12 (2010), 809–818.
67. Hwang, D.Y., Cho, J.S., Oh, J.H., Shim, S.B., Jee, S.W., Lee, S.H., Seo, S.J., Lee, S.K., Lee, S.H., Kim, Y.K., Differentially expressed genes in transgenic mice carrying human mutant presenilin-2 (N141I): correlation of selenoprotein M with Alzheimer's disease. Neurochem. Res. 30 (2005), 1009–1019.
68. Brunello, L., Zampese, E., Florean, C., Pozzan, T., Pizzo, P., Fasolato, C., Presenilin-2 dampens intracellular Ca2+ stores by increasing Ca2+ leakage and reducing Ca2+ uptake. J. Cell. Mol. Med. 13 (2009), 3358–3369.
69. Zampese, E., Fasolato, C., Kipanyula, M.J., Bortolozzi, M., Pozzan, T., Pizzo, P., Presenilin 2 modulates endoplasmic reticulum (ER)-mitochondria interactions and Ca2+ cross-talk. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 2777–2782.
70. Ferreiro, E., Oliveira, C.R., Pereira, C.M., The release of calcium from the endoplasmic reticulum induced by amyloid-beta and prion peptides activates the mitochondrial apoptotic pathway. Neurobiol. Dis. 30 (2008), 331–342.
71. Resende, R., Ferreiro, E., Pereira, C., Resende de Oliveira, C., Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1–42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death. Neuroscience 155 (2008), 725–737.
72. Chen, P., Wang, R.R., Ma, X.J., Liu, Q., Ni, J.Z., Different forms of selenoprotein M differentially affect abeta aggregation and ROS generation. Int. J. Mol. Sci. 14 (2013), 4385–4399.
73. Du, X., Li, H., Wang, Z., Qiu, S., Liu, Q., Ni, J., Selenoprotein P and selenoprotein M block Zn2+ -mediated Abeta42 aggregation and toxicity. Metallomics 5 (2013), 861–870.
74. Yim, S.Y., Chae, K.R., Shim, S.B., Hong, J.T., Park, J.Y., Lee, C.Y., Son, H.J., Sheen, Y.Y., Hwang, D.Y., ERK activation induced by selenium treatment significantly downregulates beta/gamma-secretase activity and Tau phosphorylation in the transgenic rat overexpressing human selenoprotein M. Int. J. Mol. Med. 24 (2009), 91–96.
75. Kim, Y., Goo, J.S., Kim, I.Y., Kim, J.E., Kwak, M.H., Go, J., Shim, S., Hong, J.T., Hwang, D.Y., Seong, J.K., Identification of the responsible proteins for increased selenium bioavailability in the brain of transgenic rats overexpressing selenoprotein M. Int. J. Mol. Med. 34 (2014), 1688–1698.
76. Lescure, A., Gautheret, D., Carbon, P., Krol, A., Novel selenoproteins identified in silico and in vivo by using a conserved RNA structural motif. J. Biol. Chem. 274 (1999), 38147–38154.
77. Castets, P., Lescure, A., Guicheney, P., Allamand, V., Selenoprotein N in skeletal muscle: from diseases to function. J Mol Med (Berl) 90 (2012), 1095–1107.
78. Moghadaszadeh, B., Petit, N., Jaillard, C., Brockington, M., Quijano Roy, S., Merlini, L., Romero, N., Estournet, B., Desguerre, I., Chaigne, D., Muntoni, F., Topaloglu, H., Guicheney, P., Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Nat. Genet. 29 (2001), 17–18.
79. Rederstorff, M., Castets, P., Arbogast, S., Laine, J., Vassilopoulos, S., Beuvin, M., Dubourg, O., Vignaud, A., Ferry, A., Krol, A., Allamand, V., Guicheney, P., Ferreiro, A., Lescure, A., Increased muscle stress-sensitivity induced by selenoprotein N inactivation in mouse: a mammalian model for SEPN1-related myopathy. PLoS One, 6, 2011, e23094.
80. Maiti, B., Arbogast, S., Allamand, V., Moyle, M.W., Anderson, C.B., Richard, P., Guicheney, P., Ferreiro, A., Flanigan, K.M., Howard, M.T., A mutation in the SEPN1 selenocysteine redefinition element (SRE) reduces selenocysteine incorporation and leads to SEPN1-related myopathy. Hum. Mutat. 30 (2009), 411–416.
81. Arbogast, S., Ferreiro, A., Selenoproteins and protection against oxidative stress: selenoprotein N as a novel player at the crossroads of redox signaling and calcium homeostasis. Antioxid. Redox Signal. 12 (2010), 893–904.
82. Lescure, A., Rederstorff, M., Krol, A., Guicheney, P., Allamand, V., Selenoprotein function and muscle disease. Biochim. Biophys. Acta 2009 (1790), 1569–1574.
83. Marino, M., Stoilova, T., Giorgi, C., Bachi, A., Cattaneo, A., Auricchio, A., Pinton, P., Zito, E., SEPN1, an endoplasmic reticulum-localized selenoprotein linked to skeletal muscle pathology, counteracts hyperoxidation by means of redox-regulating SERCA2 pump activity. Hum. Mol. Genet. 24 (2015), 1843–1855.
84. Arbogast, S., Beuvin, M., Fraysse, B., Zhou, H., Muntoni, F., Ferreiro, A., Oxidative stress in SEPN1-related myopathy: from pathophysiology to treatment. Ann. Neurol. 65 (2009), 677–686.
85. Appenzeller-Herzog, C., Simmen, T., ER-luminal thiol/selenol-mediated regulation of Ca2+ signalling. Biochem. Soc. Trans. 44 (2016), 452–459.
86. Dai, Y., Liang, S., Huang, Y., Chen, L., Banerjee, S., Targeted next generation sequencing identifies two novel mutations in SEPN1 in rigid spine muscular dystrophy 1. Oncotarget 7 (2016), 83843–83849.
87. Petit, N., Lescure, A., Rederstorff, M., Krol, A., Moghadaszadeh, B., Wewer, U.M., Guicheney, P., Selenoprotein N: an endoplasmic reticulum glycoprotein with an early developmental expression pattern. Hum. Mol. Genet. 12 (2003), 1045–1053.
88. Dominguez, D.C., Guragain, M., Patrauchan, M., Calcium binding proteins and calcium signaling in prokaryotes. Cell Calcium 57 (2015), 151–165.
89. Jurynec, M.J., Xia, R., Mackrill, J.J., Gunther, D., Crawford, T., Flanigan, K.M., Abramson, J.J., Howard, M.T., Grunwald, D.J., Selenoprotein N is required for ryanodine receptor calcium release channel activity in human and zebrafish muscle. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 12485–12490.
90. Deniziak, M., Thisse, C., Rederstorff, M., Hindelang, C., Thisse, B., Lescure, A., Loss of selenoprotein N function causes disruption of muscle architecture in the zebrafish embryo. Exp. Cell Res. 313 (2007), 156–167.
91. Walder, K., Kantham, L., McMillan, J.S., Trevaskis, J., Kerr, L., De Silva, A., Sunderland, T., Godde, N., Gao, Y., Bishara, N., Windmill, K., Tenne-Brown, J., Augert, G., Zimmet, P.Z., Collier, G.R., Tanis: a link between type 2 diabetes and inflammation?. Diabetes 51 (2002), 1859–1866.
92. Bubenik, J.L., Miniard, A.C., Driscoll, D.M., Alternative transcripts and 3’UTR elements govern the incorporation of selenocysteine into selenoprotein S. PLoS One, 8, 2013, e62102.
93. Lee, J.H., Kwon, J.H., Jeon, Y.H., Ko, K.Y., Lee, S.R., Kim, I.Y., Pro178 and Pro183 of selenoprotein S are essential residues for interaction with p97(VCP) during endoplasmic reticulum-associated degradation. J. Biol. Chem. 289 (2014), 13758–13768.
94. Ye, Y., Shibata, Y., Yun, C., Ron, D., Rapoport, T.A., A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429 (2004), 841–847.
95. Xia, D., Tang, W.K., Ye, Y., Structure and function of the AAA+ ATPase p97/Cdc48p. Gene 583 (2016), 64–77.
96. Liu, J., Li, F., Rozovsky, S., The intrinsically disordered membrane protein selenoprotein S is a reductase in vitro. Biochemistry 52 (2013), 3051–3061.
97. Liu, J., Rozovsky, S., Contribution of selenocysteine to the peroxidase activity of selenoprotein S. Biochemistry 52 (2013), 5514–5516.
98. Christensen, L.C., Jensen, N.W., Vala, A., Kamarauskaite, J., Johansson, L., Winther, J.R., Hofmann, K., Teilum, K., Ellgaard, L., The human selenoprotein VCP-interacting membrane protein (VIMP) is non-globular and harbors a reductase function in an intrinsically disordered region. J. Biol. Chem. 287 (2012), 26388–26399.
99. Gao, Y., Hannan, N.R., Wanyonyi, S., Konstantopolous, N., Pagnon, J., Feng, H.C., Jowett, J.B., Kim, K.H., Walder, K., Collier, G.R., Activation of the selenoprotein SEPS1 gene expression by pro-inflammatory cytokines in HepG2 cells. Cytokine 33 (2006), 246–251.
100. Curran, J.E., Jowett, J.B., Elliott, K.S., Gao, Y., Gluschenko, K., Wang, J., Abel Azim, D.M., Cai, G., Mahaney, M.C., Comuzzie, A.G., Dyer, T.D., Walder, K.R., Zimmet, P., MacCluer, J.W., Collier, G.R., Kissebah, A.H., Blangero, J., Genetic variation in selenoprotein S influences inflammatory response. Nat. Genet. 37 (2005), 1234–1241.
101. Gao, Y., Feng, H.C., Walder, K., Bolton, K., Sunderland, T., Bishara, N., Quick, M., Kantham, L., Collier, G.R., Regulation of the selenoprotein SelS by glucose deprivation and endoplasmic reticulum stress − SelS is a novel glucose-regulated protein. FEBS Lett. 563 (2004), 185–190.
102. Rueli, R.H., Torres, D.J., Dewing, A.S., Kiyohara, A.C., Barayuga, S.M., Bellinger, M.T., Uyehara-Lock, J.H., White, L.R., Moreira, P.I., Berry, M.J., Perry, G., Bellinger, F.P., Selenoprotein S reduces endoplasmic reticulum stress-induced phosphorylation of tau: potential role in selenate mitigation of tau pathology. J. Alzheimers Dis. 55 (2017), 749–762.
103. Kryukov, G.V., Kryukov, V.M., Gladyshev, V.N., New mammalian selenocysteine-containing proteins identified with an algorithm that searches for selenocysteine insertion sequence elements. J. Biol. Chem. 274 (1999), 33888–33897.
104. Boukhzar, L., Tanguy, Y., Abid, H., Castex, M., Hamieh, A., Alsharif, I., Cartier, D., Prevost, G., Falluel-Morel, A., Librmann, I., Chagraoui, A., Anouar, Y., Selenoprotein T: from discovery to functional studies using conditional knockout mice. Hatfield, D.L., Schweizer, U., Tsuji, P.A., Gladyshev, V.N., (eds.) Selenium: Its Moleculr Biology and Role in Human Health, 2016, Springer, New York, 275–286.
105. Boukhzar, L., Hamieh, A., Cartier, D., Tanguy, Y., Alsharif, I., Castex, M., Arabo, A., El Hajji, S., Bonnet, J.J., Errami, M., Falluel-Morel, A., Chagraoui, A., Lihrmann, I., Anouar, Y., Selenoprotein T exerts an essential oxidoreductase activity that protects dopaminergic neurons in mouse models of Parkinson's disease. Antioxid. Redox Signal. 24 (2016), 557–574.
106. Tanguy, Y., Falluel-Morel, A., Arthaud, S., Boukhzar, L., Manecka, D.L., Chagraoui, A., Prevost, G., Elias, S., Dorval-Coiffec, I., Lesage, J., Vieau, D., Lihrmann, I., Jegou, B., Anouar, Y., The PACAP-regulated gene selenoprotein T is highly induced in nervous, endocrine, and metabolic tissues during ontogenetic and regenerative processes. Endocrinology 152 (2011), 4322–4335.
107. Prevost, G., Arabo, A., Jian, L., Quelennec, E., Cartier, D., Hassan, S., Falluel-Morel, A., Tanguy, Y., Gargani, S., Lihrmann, I., Kerr-Conte, J., Lefebvre, H., Pattou, F., Anouar, Y., The PACAP-regulated gene selenoprotein T is abundantly expressed in mouse and human beta-cells and its targeted inactivation impairs glucose tolerance. Endocrinology 154 (2013), 3796–3806.
108. Grumolato, L., Ghzili, H., Montero-Hadjadje, M., Gasman, S., Lesage, J., Tanguy, Y., Galas, L., Ait-Ali, D., Leprince, J., Guerineau, N.C., Elkahloun, A.G., Fournier, A., Vieau, D., Vaudry, H., Anouar, Y., Selenoprotein T is a PACAP-regulated gene involved in intracellular Ca2+ mobilization and neuroendocrine secretion. FASEB J. 22 (2008), 1756–1768.
109. Li, J.P., Zhou, J.X., Wang, Q., Gu, G.Q., Yang, S.J., Li, C.Y., Qiu, C.W., Deng, G.Z., Guo, M.Y., Se enhances MLCK activation by regulating selenoprotein T (SelT) in the gastric smooth muscle of rats. Biol. Trace Elem. Res. 173 (2016), 116–125.
110. Castex, M.T., Arabo, A., Benard, M., Roy, V., Le Joncour, V., Prevost, G., Bonnet, J.J., Anouar, Y., Falluel-Morel, A., Selenoprotein T deficiency leads to neurodevelopmental abnormalities and hyperactive behavior in mice. Mol. Neurobiol. 53 (2016), 5818–5832.
111. Bianco, A.C., Salvatore, D., Gereben, B., Berry, M.J., Larsen, P.R., Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr. Rev. 23 (2002), 38–89.
112. Arrojo, E.D.R., Bianco, A.C., Type 2 deiodinase at the crossroads of thyroid hormone action. Int. J. Biochem. Cell Biol. 43 (2011), 1432–1441.
113. Baqui, M.M., Gereben, B., Harney, J.W., Larsen, P.R., Bianco, A.C., Distinct subcellular localization of transiently expressed types 1 and 2 iodothyronine deiodinases as determined by immunofluorescence confocal microscopy. Endocrinology 141 (2000), 4309–4312.
114. Dentice, M., Bandyopadhyay, A., Gereben, B., Callebaut, I., Christoffolete, M.A., Kim, B.W., Nissim, S., Mornon, J.P., Zavacki, A.M., Zeold, A., Capelo, L.P., Curcio-Morelli, C., Ribeiro, R., Harney, J.W., Tabin, C.J., Bianco, A.C., The Hedgehog-inducible ubiquitin ligase subunit WSB-1 modulates thyroid hormone activation and PTHrP secretion in the developing growth plate. Nat. Cell Biol. 7 (2005), 698–705.
115. Zavacki, A.M., Arrojo, E.D.R., Freitas, B.C., Chung, M., Harney, J.W., Egri, P., Wittmann, G., Fekete, C., Gereben, B., Bianco, A.C., The E3 ubiquitin ligase TEB4 mediates degradation of type 2 iodothyronine deiodinase. Mol. Cell. Biol. 29 (2009), 5339–5347.
116. Arrojo, E.D.R., Egri, P., Jo, S., Gereben, B., Bianco, A.C., The type II deiodinase is retrotranslocated to the cytoplasm and proteasomes via p97/Atx3 complex. Mol. Endocrinol. 27 (2013), 2105–2115.
117. Curcio-Morelli, C., Zavacki, A.M., Christofollete, M., Gereben, B., de Freitas, B.C., Harney, J.W., Li, Z., Wu, G., Bianco, A.C., Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation. J. Clin. Invest. 112 (2003), 189–196.
118. Arrojo, E.D.R., Fonseca, T.L., Castillo, M., Salathe, M., Simovic, G., Mohacsik, P., Gereben, B., Bianco, A.C., Endoplasmic reticulum stress decreases intracellular thyroid hormone activation via an eIF2a-mediated decrease in type 2 deiodinase synthesis. Mol. Endocrinol. 25 (2011), 2065–2075.
119. Accorroni, A., Saponaro, F., Zucchi, R., Tissue thyroid hormones and thyronamines. Heart Fail. Rev. 21 (2016), 373–390.
120. Kahaly, G.J., Dillmann, W.H., Thyroid hormone action in the heart. Endocr. Rev. 26 (2005), 704–728.
121. Pachucki, J., Hopkins, J., Peeters, R., Tu, H., Carvalho, S.D., Kaulbach, H., Abel, E.D., Wondisford, F.E., Ingwall, J.S., Larsen, P.R., Type 2 iodothyronin deiodinase transgene expression in the mouse heart causes cardiac-specific thyrotoxicosis. Endocrinology 142 (2001), 13–20.